Industry

Recursion Pharmaceuticals

A clinical-stage biotech decoding biology at scale, pairing automated cell experiments with machine learning to discover and develop new medicines.

Location: Salt Lake City, UT
Website
4 models(2 Protein, 1 Small molecule, 1 Single-cell, 1 Imaging)

Models (4)

Nesso-1

Recursion Pharmaceuticals

Released July 20, 2026

118

Protein-ligand binding affinity prediction from sequence and SMILES, without MSAs. Coarse-grained cofolding runs over 10x faster than Boltz-2.

ProteinSmall molecule

TxFM

Recursion Pharmaceuticals

Released May 31, 2026

2

Transcriptomics foundation model from Recursion that masks and reconstructs RNA-seq gene expression counts to learn reusable sample embeddings.

Single-cell

Boltz-2

MIT CSAIL / Recursion Pharmaceuticals

Released June 1, 2025

4904.1K

Open model that jointly predicts biomolecular structure and small-molecule binding affinity, approaching FEP+ accuracy in seconds on a single GPU.

Protein

OpenPhenom-S/16

Recursion Pharmaceuticals

Released November 12, 2024

888.8K78

Cell Painting microscopy foundation model, a channel-agnostic masked autoencoder producing morphological embeddings for zero-shot phenotypic analysis.

Imaging